Metraipolis › archive › dc_b277a2f42fe4

Malondialdehyde as a Predictor of Disease Severity and Cardiovascular Risk in Population with Metabolic Dysfunction-Associated Steatotic Liver Disease — Europe PMC PMID:41893352

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41893352
DOI
10.3390/metabo16030203
License (as archived)
solo-consultazione
Archived
2026-11-04T05:55:26.583Z
SHA-256 of the archived text
2203eaa3f6c18d257a8218c725b3fc85b52e8fabb807a61e08e0f2a49ae64c83
Stable URL of this page
https://metraipolis.com/documento/dc_b277a2f42fe4

How to cite

Malondialdehyde as a Predictor of Disease Severity and Cardiovascular Risk in Population with Metabolic Dysfunction-Associated Steatotic Liver Disease — Europe PMC PMID:41893352 — Europe PMC (en), https://europepmc.org/article/MED/41893352 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b277a2f42fe4 (Metraipolis archive dc_b277a2f42fe4, sha256 2203eaa3f6c18d257a8218c725b3fc85b52e8fabb807a61e08e0f2a49ae64c83)
BibTeX
@misc{dcb277a2f42fe4,
  title = {Malondialdehyde as a Predictor of Disease Severity and Cardiovascular Risk in Population with Metabolic Dysfunction-Associated Steatotic Liver Disease — Europe PMC PMID:41893352},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41893352},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b277a2f42fe4; sha256 2203eaa3f6c18d257a8218c725b3fc85b52e8fabb807a61e08e0f2a49ae64c83},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41893352. Agents can read the archived copy with the MCP tool read_document.